Clinical Trial

Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

Name: Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study — clinical trial record (NCT07622108)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the efficacy of MHB018A injection compared with placebo in participants with active moderate-to-severe TED.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-05-27.

Trial Details

NCT Number	NCT07622108
Lead Sponsor	Minghui Pharmaceutical (Hangzhou) Ltd
Conditions	Thyroid Eye Disease, TED
Enrollment	84 participants
Start Date	2026-12
Primary Completion	2028-07 (estimated)
Study Completion	2029-07 (estimated)
Updated on ClinicalTrials.gov	2026-06-04